logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 5
  • 1
    Bellemin, Jean-marc
    Born in April 1972
    Individual (3 offsprings)
    Officer
    2020-05-29 ~ 2020-12-11
    OF - Director → CIF 0
  • 2
    Economides, Vassiliki
    Born in June 1979
    Individual (1 offspring)
    Officer
    2023-07-12 ~ now
    OF - Director → CIF 0
  • 3
    Allen, Andrew, Dr
    Chief Executive Officer born in May 1966
    Individual (7 offsprings)
    Officer
    2020-05-29 ~ 2024-12-31
    OF - Director → CIF 0
  • 4
    Thompson, Rahsaan
    Born in December 1970
    Individual (1 offspring)
    Officer
    2020-05-29 ~ 2022-09-27
    OF - Director → CIF 0
  • 5
    GRITSTONE BIOPHARMACEUTICALS UK LTD 12631333
    Suite 300, 5959 Horton Street, Emeryville, California, United States
    Dissolved Corporate (5 parents, 1 offspring)
    Person with significant control
    2020-05-29 ~ dissolved
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

GRITSTONE BIOPHARMACEUTICALS UK LTD

Period: 2020-05-29 ~ 2025-05-27
Company number: 12631333
Registered name
GRITSTONE BIOPHARMACEUTICALS UK LTD - Dissolved
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Called-up share capital not yet paid and not classified as a current asset
1 GBP2024-05-31
1 GBP2023-05-31
Net Assets/Liabilities
1 GBP2024-05-31
1 GBP2023-05-31
Number of shares allotted
Class 1 ordinary share
1 shares2023-06-01 ~ 2024-05-31
Par Value of Share
Class 1 ordinary share
1 GBP/shares2023-06-01 ~ 2024-05-31
Equity
1 GBP2024-05-31
1 GBP2023-05-31

Related profiles found in government register
  • GRITSTONE BIOPHARMACEUTICALS UK LTD
    Info
    Registered number 12631333
    C/o Arnold & Porter Kaye Scholer (uk) Llp Tower 42, 25 Old Broad Street, London EC2N 1HQ
    PRIVATE LIMITED COMPANY incorporated on 2020-05-29 and dissolved on 2025-05-27 (4 years 11 months). The status of the company number is Dissolved.
    The last date of confirmation statement was made at 2024-05-28
    CIF 0
  • GRITSTONE BIO, INC.
    S
    Registered number missing
    Suite 300, 5959 Horton Street, Emeryville, California, United States, 94608
    Corporation
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    GRITSTONE BIOPHARMACEUTICALS UK LTD
    12631333
    C/o Arnold & Porter Kaye Scholer (uk) Llp Tower 42, 25 Old Broad Street, London, United Kingdom
    Dissolved Corporate (5 parents, 1 offspring)
    Person with significant control
    2020-05-29 ~ dissolved
    CIF 1 - Ownership of voting rights - 75% or more OE
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Right to appoint or remove directors OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.